Form D — Immunis, Inc.
0002028798-26-000003 · filed Jun 15, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $11,975,000
- Reported amount sold
- $11,975,000
- Minimum investment
- $50,000
- Investors
- 12
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Immunis, Inc.
- CIK
- 2028798
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 18301 Von Karman Avenue
Irvine, CA 92612 - Phone
- (949) 266-2501
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Hans Keirstead · Executive OfficerIrvine, CA Find on LinkedIn ↗
-
Takahide Koda · DirectorIrvine, CA Find on LinkedIn ↗
-
Daniel Kraft · DirectorIrvine, CA Find on LinkedIn ↗
-
Gabriel Nistor · Executive OfficerIrvine, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗